MedPath

BAYER HEALTHCARE LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

88

PPB:88

Drug Approvals

EYLEA SOLUTION FOR INTRAVITREAL INJECTION 114.3MG/ML

Approval Date
Sep 6, 2024
PPB

XARELTO TABLETS 10MG

Approval Date
Sep 4, 2024
PPB

XARELTO TABLETS 20MG

Approval Date
Sep 4, 2024
PPB

XARELTO TABLETS 15MG

Approval Date
Sep 4, 2024
PPB

KERENDIA TABLETS 20MG

Approval Date
Oct 25, 2022
PPB

KERENDIA TABLETS 10MG

Approval Date
Oct 25, 2022
PPB

XARELTO GRANULES FOR ORAL SUSPENSION 1MG/ML

Approval Date
Jul 13, 2022
PPB

VERQUVO TABLETS 2.5MG

Approval Date
Apr 29, 2022
PPB

VERQUVO TABLETS 5MG

Approval Date
Apr 29, 2022
PPB

VERQUVO TABLETS 10MG

Approval Date
Apr 29, 2022
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.